@RecentlyTrain484 9 months ago
Axsome shares just surged after FDA granted them Priority review
Axsome shares just surged after FDA granted them Priority review
's share jumped around 20%....DAMN
There was news that the FDA granted priority review to its application for AXS-05, which is targeted at agitation in Alzheimer’s patients. It's a really positive move for the company, the FDA has also shown its support for another one of their drugs called AXS-12. I think this might be a good stock to invest in
@Deep_Brief438 9 months ago
The FDA priority review is a big catalyst. curious if it can hold after the pop.
